Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells
1996

Effects of Vitamin D and Retinoids on Pancreatic Cancer Cells

publication Evidence: moderate

Author Information

Author(s): G Zugmaier, R Jigerl, B Grage, MM Gottardis, K Havemann, C Knabbe

Primary Institution: Marburg University Medical Center

Hypothesis

The study investigates the growth-inhibitory effects of vitamin D analogue EB1089 and retinoids on human pancreatic cancer cell lines.

Conclusion

The combination of vitamin D analogue EB1089 and all-trans-retinoic acid significantly inhibits the growth of certain pancreatic cancer cell lines.

Supporting Evidence

  • All-trans-retinoic acid inhibited the growth of Capan 1 and Capan 2 cells by 40%.
  • The combination of 1 nM EB1089 with 10 nM all-trans-retinoic acid inhibited growth by 90% in Capan 1 cells.
  • 9-cis-Retinoic acid was less effective than all-trans-retinoic acid.
  • EB1089 alone did not significantly inhibit growth.

Takeaway

This study found that a mix of vitamin D and a type of vitamin A can help stop some pancreatic cancer cells from growing.

Methodology

The study used cell culture and proliferation assays to test the effects of vitamin D analogue EB1089 and retinoids on pancreatic cancer cell lines.

Limitations

The study did not include in vivo experiments to confirm the effects observed in vitro.

Statistical Information

P-Value

<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication